France vs Latvia: Colon and rectum cancer screening coverage in Europe
France
29.6%
in 2024
Latvia
28.0%
in 2025
France rank
15th
Latvia rank
16th
Colon and rectum cancer screening coverage in Europe over time
- France
- Latvia
How they compare
France currently reports 29.6% against 28.0% in Latvia, a difference of 1.6%.
That makes France's figure about 1.1 times Latvia's.
Across all 12 years both countries report, France has been ahead every year.
France ranks 15th and Latvia ranks 16th of 20 countries.
France has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | France | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 27.3% | 11.3% | 16.0% | France |
| 2020s | 28.7% | 20.8% | 7.9% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher colon and rectum cancer screening coverage in europe, France or Latvia?
- France, at 29.6% against 28.0% in Latvia as of 2024.
- What is the difference in colon and rectum cancer screening coverage in europe between France and Latvia?
- 1.6%, with France ahead.
- How many years of comparable data are there for France and Latvia?
- 12 years are reported by both, from 2011 to 2024.
- How do France and Latvia rank globally for colon and rectum cancer screening coverage in europe?
- France ranks 15th and Latvia ranks 16th of 20 countries.
- Where does this data come from?
- Eurostat (2026) – with minor processing by Our World in Data, published as Colon and rectum cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of people aged 50 to 74 years who have been screened for colon and rectum cancer within the previous 2 years.